204 related articles for article (PubMed ID: 26497978)
1. Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate.
Li P; Luo S; Pan C; Cheng X
Mol Med Rep; 2015 Dec; 12(6):7899-906. PubMed ID: 26497978
[TBL] [Abstract][Full Text] [Related]
2. [Fenofibrate improves energy metabolism and attenuates isoproterenol induced acute myocardial ischemic injury in rats via PPAR alpha activation].
Yuan J; Wu J; Han ZG
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):847-50. PubMed ID: 19102873
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Purushothaman S; Sathik MM; Nair RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
[TBL] [Abstract][Full Text] [Related]
4. Role of peroxisome proliferator-activated receptor alpha activation in acute myocardial damage induced by isoproterenol in rats.
Yuan J; Wu J; Hang ZG; Zhong XK; Zhou LW; Yu B
Chin Med J (Engl); 2008 Aug; 121(16):1569-73. PubMed ID: 18982870
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
Jen HL; Yin WH; Chen JW; Lin SJ
J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
[TBL] [Abstract][Full Text] [Related]
6. Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD: Accuracy of non- invasive panel in determining the stage of liver fibrosis in rats.
Hamed AM; El-Kharashi OA; Boctor SS; Abd-Elaziz LF
Biomed Pharmacother; 2017 Jan; 85():68-78. PubMed ID: 27930988
[TBL] [Abstract][Full Text] [Related]
7. [Effects of beta3-adrenergic receptor antagonist on myocardial UCP2 expression and energy metabolism in chronic heart failure rats].
Gao YH; Gao HB; Di NN; Kong YH; Li WM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Jul; 29(4):376-9, 384. PubMed ID: 24175568
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor 11 is involved in isoproterenol‑induced heart failure.
Zhang XJ; Tan H; Shi ZF; Li N; Jia Y; Hao Z
Mol Med Rep; 2019 May; 19(5):4109-4118. PubMed ID: 30942402
[TBL] [Abstract][Full Text] [Related]
10. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rb1 promotes the activation of PPARα pathway via inhibiting FADD to ameliorate heart failure.
Li C; Zhang X; Li J; Liang L; Zeng J; Wen M; Pan L; Lv D; Liu M; Cheng Y; Huang H
Eur J Pharmacol; 2023 May; 947():175676. PubMed ID: 37001580
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha.
Nagai Y; Nishio Y; Nakamura T; Maegawa H; Kikkawa R; Kashiwagi A
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1180-90. PubMed ID: 11934685
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARα pathway.
Chen X; Wang Q; Shao M; Ma L; Guo D; Wu Y; Gao P; Wang X; Li W; Li C; Wang Y
Biomed Pharmacother; 2019 Dec; 120():109487. PubMed ID: 31577975
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation.
Dong Z; Zhao P; Xu M; Zhang C; Guo W; Chen H; Tian J; Wei H; Lu R; Cao T
Sci Rep; 2017 Jun; 7(1):2691. PubMed ID: 28578382
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
[TBL] [Abstract][Full Text] [Related]
17. Reversal of isoproterenol-induced downregulation of phospholamban and FKBP12.6 by CPU0213-mediated antagonism of endothelin receptors.
Feng Y; Tang XY; Dai DZ; Dai Y
Acta Pharmacol Sin; 2007 Nov; 28(11):1746-54. PubMed ID: 17959025
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.
Okamoto H; Iwamoto T; Kotake S; Momohara S; Yamanaka H; Kamatani N
Clin Exp Rheumatol; 2005; 23(3):323-30. PubMed ID: 15971419
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate ameliorates neural, mechanical, chemical, and electrical alterations in the murine model of heart failure.
Dhyani N; Saidullah B; Fahim M; Omanwar S
Hum Exp Toxicol; 2019 Oct; 38(10):1183-1194. PubMed ID: 31256679
[TBL] [Abstract][Full Text] [Related]
20. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
